Unknown

Dataset Information

Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure.


ABSTRACT:

Background

Heart failure is a major cause of morbidity and mortality worldwide. The ubiquitously expressed cytokine transforming growth factor-β1 (TGFβ1) promotes cardiac fibrosis, an important component of progressive heart failure. Membrane-associated endoglin is a coreceptor for TGFβ1 signaling and has been studied in vascular remodeling and preeclampsia. We hypothesized that reduced endoglin expression may limit cardiac fibrosis in heart failure.

Methods and results

We first report that endoglin expression is increased in the left ventricle of human subjects with heart failure and determined that endoglin is required for TGFβ1 signaling in human cardiac fibroblasts using neutralizing antibodies and an siRNA approach. We further identified that reduced endoglin expression

SUBMITTER: Kapur NK 

PROVIDER: S-EPMC4774533 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature